Cite
MLA Citation
Wells Messersmith et al.. “389 Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumors.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A414. http://access.bl.uk/ark:/81055/vdc_100144723823.0x000003